ProQR Therapeutics (PRQR) Non-Current Assets (2013 - 2025)

ProQR Therapeutics' Non-Current Assets history runs 13 years deep, the most recent figure standing at $14.7 million for Q4 2025.

• In Q4 2025, Non-Current Assets fell 2.51% year-over-year to $14.7 million; the TTM figure through Dec 2025 stood at $14.7 million (down 2.51% YoY), while the FY2025 annual figure was $14.7 million, down 2.51% from the prior year.
• Non-Current Assets came in at $14.7 million for Q4 2025 at ProQR Therapeutics, down from $15.1 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $110.5 billion in Q1 2021 to a low of $14.7 million in Q4 2025.
• A 5-year average of $7.9 billion and a median of $18.6 million in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets jumped 3870662.42% in 2021 and plunged 99.98% in 2022, its largest moves.
• ProQR Therapeutics' Non-Current Assets stood at $20.7 million in 2021, then dropped by 16.9% to $17.2 million in 2022, then grew by 5.68% to $18.2 million in 2023, then declined by 17.05% to $15.1 million in 2024, then slipped by 2.51% to $14.7 million in 2025.
• According to Business Quant data, Non-Current Assets over the past three periods registered $14.7 million, $15.1 million, and $18.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison